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1. Introduction 
Airborne contaminants occur in the gaseous form (gases and vapours) or as aerosols. 
Aerosols may exist in the form of airborne dusts, sprays, mists, smokes and fumes. In the 
occupational setting, all these forms may be important because they relate to a wide range of 
occupational diseases. Airborne dusts are of particular concern because they are well known 
to be associated with classical widespread occupational lung diseases such as the 
pneumoconiosis, chronic obstructive pulmonary disease, occupational asthma, etc. 
Occupational exposure to dust particles occurs everywhere but is especially prevalent in 
low- and middle-income countries. Table 1 shows some examples of the types of dust found 
in the work environment. 
 
TYPE OF DUST EXAMPLES 
mineral dusts free crystalline silica, coal and cement dusts 
metallic dusts lead, cadmium, nickel, and beryllium dusts 
other chemical dusts many bulk chemicals and pesticides 
organic and vegetable dusts flour, wood, cotton and tea dusts, pollen 
biohazards viable particles, moulds and spores 
Table 1. Common types of dust in the work envrionment 
2. Commonest type of occupation dust particles 
2.1 Silica 
Silica, also known as silicon dioxide (SiO2), is formed from silicon and oxygen atoms. It has 
a melting point of 1,600°C and is a colorless, odorless, and noncombustible solid. Since 
oxygen and silicon make up about 75% of the Earth, the compound silica is quite common in 
surrounding environment1. Silicates comprise about 25% of known minerals, nearly 40% of 
the common minerals, and well over 90% of the earth’s crust[1]. It is found in many rocks, 
such as marble, sandstone, flint and slate, and in some metallic ores. Silica can also be in soil, 
mortar, plaster, and shingles. 
Silica occurs in three forms: crystalline, microcrystalline (or cryptocrystalline) and 
amorphous (non-crystalline). "Free" silica is composed of pure silicon dioxide, not combined 
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with other elements, whereas silicates (e.g. talc, asbestos, and mica) are SiO2 combined with 
an appreciable portion of cations. Crystalline silica exists in seven different forms 
(polymorphs), depending upon the temperature of formation. The main 3 polymorphs are 
quartz, cristobalite, and tridymite. Quartz is subdivided into alpha and beta forms. In 
nature, most quartz is alpha-quartz and alpha-quartz comprises the bulk of crystalline silica. 
Quartz is the second most common mineral in the world. Amorphous forms of silica, such 
as opal, diatomaceous earth, silica-rich fiberglass, fume silica, mineral wool, and silica glass 
(vitreous silica), are generally considered as less harmful[2]. 
Occupational exposure to crystalline silica can occur in any workplace situation where 
airborne dust, containing a proportion of crystalline silica, is generated. Industries where 
crystalline silica is present include quarrying, mining, mineral processing (eg drying, 
grinding, bagging and handling), slate working, stone crushing and dressing, foundry work, 
brick and tile making, some refractory processes, construction work, including work with 
stone, concrete, brick and some insulation boards, tunnelling, building restoration and in the 
pottery and ceramic industries. Figure 1 shows some of the job processes that generate and 
disperse large quantities of respirable silica dusts into the air. Silica dust is an inhalation 
hazard. Workers may be at risk of silicosis from exposure to silica dust when high-velocity 
impact shatters the sand into smaller, respirable (< 0.5 to 5.0 µm in diameter) dust particles. 
From recent reports, more than 23 million workers are exposed to crystalline silica in China  
   
 
Fig. 1. Job processes that generate and disperse respirable silica dusts into the air 
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and more than 10 million in India, as well as over 3 million workers in Europe and at 1.7 
million in the United States[3]. 
2.2 Asbestos 
Asbestos is a set of six naturally occurring silicate minerals exploited commercially which 
possess high tensile strength, flexibility, resistance to chemical and thermal degradation, 
and electrical resistance. Six minerals are defined by the United States Environmental 
Protection Agency as "asbestos" including those belonging to the serpentine class chrysotile 
and those belonging to the amphibole class amosite, crocidolite, tremolite, anthophyllite and 
actinolite[4]. They have different physical and chemical properties but share a fibrous form. 
Mineralogists have taken a particle with a length-to-breadth ratio (aspect ratio) of 10:1 or 
more to be a fibre. In milled asbestos most of the particles have aspect ratios that range from 
5:1 to 20:1 or more and, in the case of chrysotile , mostly greater than 50:1. In medical and 
environmental literature a regulated fibre has been defined as a mineral particle with a 
length which is at least three times greater than its diameter, of length greater than 5 
micrometers and diameters less than 3 micrometres. There are essentially two major 
varieties of asbestos viz. serpentine and amphibole. Table 2 shows the species and 
varieties[5]. 
 
SPECIES VARIETY 
Chrysotile Serpentine 
Anthophyllite Amphibole 
Amosite Amphibole 
Actinolite Amphibole 
Tremolite Amphibole 
Crocidolite Amphibole 
Table 2. Asbestos  
Asbestos is used for insulation in buildings and as ingredient in a number of products, such 
as roofing shingles, water supply lines, fire blankets, plastic fillers, and medical packing, as 
well as clutches and brake linings, gaskets and pads for automobiles. Table 3 illustrates 
certain kinds of work involve high exposure to asbestos. All forms of asbestos are 
 
work involve high exposure to asbestos 
asbestos mining and milling 
building demolition 
manufacture of brake linings 
shipbuilding trades 
insulation work in construction 
plasterers 
pipe fitters 
railroad workers 
manufacture of asbestos tiles 
manufacture of asbestos fabrics 
drywall installation 
drywall removal 
other asbestos removal 
firefighting 
asbestos tile setters 
aluminum plant workers 
Table 3. Certain kinds of work involve high exposure to asbestos 
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carcinogenic to humans, and may cause mesothelioma and cancer of the lung, larynx and 
ovary. Asbestos exposure is also responsible for other diseases, such as asbestosis (fibrosis of 
the lungs), pleural plaques, thickening and effusions. 
Currently, about 125 million people in the world are exposed to asbestos at the workplace. 
According to the most recent WHO estimates, more than 107 000 people die each year from 
asbestos-related lung cancer, mesothelioma and asbestosis resulting from exposure at work. 
One in every three deaths from occupational cancer is estimated to be caused by asbestos. In 
addition, it is estimated that several thousand deaths annually can be attributed to exposure 
to asbestos in the home[6]. 
2.3 Coal mine dust 
Coal is a valuable and plentiful natural global resource. It is found throughout the world. 
Coal is classified into four main types or ranks (anthracite, bituminous, subbituminous, and 
lignite), depending on the amounts and types of carbon it contains and on the amount of 
heat energy it can produce. Coal is mined by two methods: surface mining and 
underground mining. The choice of mining method is largely determined by the geology of 
the coal deposit. Underground mining currently accounts for a bigger share of world coal 
production than opencast. Coal mine dust is a mixture that contains more than 50 
substances. The mineral content depends on the particle size of the dust and the coal seam. 
The most commonly found minerals in coal mine dust include kaolinite, illite, calcite, pyrite 
and quartz (silica). Dust from high rank coals usually contains more silica particles than 
dust of lower rank coals. Most workplace exposure to coal dust occurs during mining; 
however exposure can also occur during handling of the mined product during cleaning 
and blending processes or bulk handling at large coal fired facilities[7]. 
3. Main respiratory diseases related to occupational dust particles 
3.1 Pneumoconiosis 
Pneumoconiosis is an occupational lung disease and a restrictive lung disease  
caused by the inhalation of dust. A longer, factitious term is 
pneumonoultramicroscopicsilicovolcanoconiosis. Depending upon the type of dust, the 
disease is given different names: 
1. Coal worker’ pneumoconiosis(CWP): caused by inhaling coal dust; 
2. Asbestosis: caused by inhaling asbestos; 
3. Berylliosis: caused by inhaling beryllium; 
4. Kaolin pneumoconiosis: caused by inhaling china clay; 
5. Siderosis: caused by inhaling iron oxide; 
6. Silicosis: caused by inhaling silica dust; 
7. Metallic pneumoconiosis: caused by inhaling barium, cobalt, tin, tungsten dust; 
8. Talc pneumoconiosis: caused by inhaling talc dust; 
9. Popcorn pneumoconiosis: caused by inhaling fumes produced when manufacturing 
microwave popcorn 
Some more types of pneumoconiosis include graphite pneumoconiosis, carbon black 
pneumoconiosis, talc pneumoconiosis, cement pneumoconiosis, mica pneumoconiosis, 
aluminosis, electric welder pneumoconiosis, foundry worker's pneumoconiosis.  
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3.2 Silicosis 
Silicosis is a form of pneumoconiosis caused by inhalation of crystalline silica dust, and is 
marked by inflammation and scarring in forms of nodular lesions in the upper lobes of the 
lungs[6] (Figure 2). 
 
Fig. 2. Silicosis showing as nodular mass on a chest x-ray 
Silicosis is the commonest occupational lung disease worldwide. It occurs everywhere but is 
especially prevalent in low- and middle-income countries. China is the country with the 
largest number of silicosis patients, with more than 500,000 cases in records from 1949 to 
2010. During 1991 to 2010, more than 6,000 new cases and more than 24,000 deaths occurred 
annually. The problem is particularly acute in small-scale mines in China[3]. High risk of 
silicosis also reported in other countries. The proportions of gold miners with silicosis 
increased from 0.03 to 0.32 for black miners and from 0.18 to 0.22 for white miners in a 33-
year period in South Africa. Among ornamental stone carvers in Brazil, the prevalence of 
disease remains over 50 percent. Although U.S. silicosis mortality declined between 1968 
and 2002, silicosis deaths and new cases continue to occur, even in young workers[6]. 
The most common form of silicosis (chronic) will often develop between 15 to 45 years after 
first exposure, but certain rare forms of the disease can occur after a single heavy dose or 
heavy exposures to a very high concentration of silica in a short period of time. Workers 
with Silicosis may have following symptoms: Shortness of breath following physical 
exertion, severe and chronic cough, fatigue, loss of appetite, chest pains and fevers. 
Silicosis is generally divided into three types as below: 
1. Acute Silicosis: Occurs after heavy exposure to high concentrations of silica. The 
symptoms can develop within a few weeks or as long as 5 years after the exposure. 
2. Chronic Silicosis: Occurs after long term exposure (over 10 years) of low concentrations 
of silica dust. This is most common form of the disease, and is often undetected for 
many years because a chest X-Ray often will not reveal the disease for as long as 20 
years after exposure. This type of the disease severely hinders the ability of the body to 
fight infections because of the damage to the lungs, making the person more susceptible 
to other lung illnesses, including tuberculosis. 
3. Accelerated Silicosis: Occurs after exposure to high concentrations of silica. The disease 
develops within 5 to 10 years after exposure. 
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The development of silicosis is associated with content of free silica in the dust, type of silica, 
concentration of dust, dispersion, years of exposure, prevention and individual factors. The 
cumulative dose of silica (respirable dust concentration x crystalline silica content x exposure 
duration) is probably the most important factor for the development of silicosis[8]. 
Pathology 
Pathological varieties of silicosis include simple (nodular) silicosis, progressive massive 
fibrosis, silicoproteinosis (acute silicosis) and diffuse interstitial fibrosis. 
Alveolar macrophages engulf inhaled free silica particles and enter lymphatics and 
interstitial tissue. The macrophages cause release of cytokines (tumor necrosis factor-┙, IL-
1), growth factors (tumor growth factor-┚), and oxidants, stimulating parenchymal 
inflammation, collagen synthesis, and, ultimately, fibrosis. 
When the macrophages die, they release the silica into interstitial tissue around the small 
bronchioles, causing formation of the pathognomonic silicotic nodule. These nodules 
initially contain macrophages, lymphocytes, mast cells, fibroblasts with disorganized 
patches of collagen, and scattered birefringent particles that are best seen by polarized light 
microscopy. As they mature, the centers of the nodules become dense balls of fibrotic scar 
with a classic onion-skin appearance and are surrounded by an outer layer of inflammatory 
cells. In low-intensity or short-term exposures, these nodules remain discrete and do not 
compromise lung function (simple chronic silicosis). But with higher-intensity or more 
prolonged exposures (complicated chronic silicosis), these nodules coalesce and cause 
progressive fibrosis and reduction of lung volumes (total lung capacity, ventilatory 
capacity) on pulmonary function tests, or they coalesce, sometimes forming large 
conglomerate masses (called progressive massive fibrosis). 
Silica quartz crystals in lung tissue can be observed under polarised light microscopy. 
Figure 3 illustrates a slide under polarised light microscopy of lung tissue containing 
crystalline silica quartz. The white spots represent silica crystals in the specimen of lung 
tissue. The silica crystals present in the lung tissue are of different size and represent  
 
Fig. 3. Lung tissue observed under polarized light microscopy containing crystalline silica 
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therefore a typical picture of silica crystal distribution in lung tissue of a worker exposed to 
crystalline silica. 
The primary feature that develops in lungs of silica quartz exposed workers is nodule 
formation in the upper zones of the lung[9]. Nodule formation is usually the result of many 
years of exposure to relatively low levels of dust that contain silica quartz[10]. Figure 4 
represents a photo of silicotic nodule. The classical silicotic nodule is usually located in the 
area of the respiratory bronchiole.The nodule is composed of reticulin fibres in the 
periphery and collagen fibresin the center. Fibroblastic activity is usually evident around the 
periphery of the concentric lesion[11]. 
 
Fig. 4. A microscopic photo of a typical silicotic nodule containing collage fibres in a 
whorled pattern 
The airway and blood vessels are frequently destroyed by being entrapped in the fibrotic 
nodule. Silica particles are difficult to identify in tissue section by polarized light 
microscopy. Therefore, special techniques involving high resoluton microscopy are 
required. It appears that the extent of lesion bears little association with amount of silica 
present[11]. 
Diagnosis 
The diagnosis of silicosis generally rests upon history of substantial exposure to silica dusts 
and compatible radiological features, together with the exclusion of other competing 
diagnoses, like miliary tuberculosis, fungal infections, sarcoidosis, idiopathic pulmonary 
fibrosis, other interstitial lung diseases, or carcinomotosis. 
History: The individual may report a history of exposure to silica dust. Although initially 
there may be no symptoms, symptoms may eventually include difficulty breathing, 
shortness of breath, a cough (either dry or productive), and/or chest tightness. 
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Physical exam: Auscultation (listening to breath sounds through a stethoscope) may reveal 
changes in breath sounds that may indicate obstruction in the upper lobes of the lung. 
Wheezing only occurs when other conditions such as bronchitis or asthma are present. In 
chronic complicated silicosis or subacute silicosis, right-sided heart failure (cor pulmonale) 
may be noted. Rales are often heard. 
Tests: Lung tissue changes in progressive silicosis are often detected by chest x-ray before 
they cause any symptoms. Pulmonary function tests will be used to evaluate lung function 
and confirm the presence of lung disorders. These may include spirometry and lung volume 
measurement to detect any restriction of normal lung expansion or obstruction of air flow, 
peak flow measurement to detect narrowing of the airways, and diffusing capacity to assess 
the efficiency of gas absorption into the blood. Arterial blood gases (ABGs) are performed to 
assess the efficiency of gas exchange in the lungs by measuring oxygen and carbon dioxide 
(CO2) in arterial blood. CT scanning may also be useful for identifying lung nodules. It’s 
generally accepted that the advent of high-resolution computed tomography (HRCT) has 
been the major diagnostic technique which is more sensitive than conventional radiography 
in detecting nodular lung parenchymal changes, progressive massive fibrosis, bulla, 
emphysema, pleural and hilar changes in silicosis. Qualitative and quantitative parameters 
on HRCT may also be used as indirect measures of functional impairment in silicosis. 
Therefore, HRCT has been widespread used. Sputum (phlegm) may be cultured to identify 
any causative organisms and to rule out tuberculosis. 
Treatment 
Damage to the lungs from silicosis is irreversible; there is no standard treatment other than 
reducing symptoms and treating complications. Lung tissue changes due to silicosis are 
often detected by a chest x-ray before they cause any symptoms. If dust exposure is stopped 
at this point, further progression of the disease can sometimes be prevented.  
The disease is otherwise treated symptomatically. Appropriate drug therapy may be given 
to control symptoms; these may include drugs to reduce inflammation (anti-inflammatory), 
antibiotics to treat or prevent infections, and drugs to widen the airways in the lungs 
(bronchodilators). Sleeping in a semi-upright position may help reduce shortness of breath. 
Because smoking can aggravate the symptoms of silicosis and increase the risk of lung 
cancer, people with the condition who smoke cigarettes are urged to quit. In severe or 
advanced cases, a lung transplant may be required[12].  
Prevention 
Silicosis are preventable. In 1995, the ILO/WHO Global Program for the Elimination of 
Silicosis (GPES) was established by a joint ILO/WHO committee. GPES is encouraging and 
supporting countries with silica hazard to establish their national action programs to control 
silicosis.  
It is recommended to assess the potential of silica exposure before a job begins, especially in 
the industries where silicosis cases were reported before[13]. Periodic respirable silica 
monitoring should be performed in all industries involving silica exposure. Currently 
enforced or suggested permissible exposure limits (PEL) for respirable silica are between 
0.025 mg/m3 and 0.35 mg/m3 in different countries [14-16]. The current standards have not 
been confirmed by epidemiology studies to be fully protective. For example, the 
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quantitative risk assessments by NIOSH predicted excess lifetime risks of 19/1000 for lung 
cancer mortality, 54/1000 for lung disease other than cancer and 75/1000 for radiographic 
silicosis with exposure at the current US Occupational Safety and Health Authority standard 
for respirable cristobalite dust (about 0.05 mg/m3) over 45-year working lifetime[17].  
For workers in workplaces with high dust levels, administrative measures can also be used 
to reduce exposure to silica dust e.g., by cutting short their working hours or job rotation. 
Exposure control at the worker level includes training and education on work practices, and 
personal protection. Personal protection equipment such as respirators is a good solution for 
short duration tasks. Respirators can be used in combination with engineering controls. 
However, they should only be considered as the last resort for routine full shift protection. 
They cannot be heavily relied upon because they may not be fully effective in workplaces 
with high dust concentrations. NIOSH recommends the use of half-facepiece particulate 
respirators with N95 or better filters for exposure to crystalline silica at concentrations less 
than or equal to 0.5mg/m3 [18].  
Regular medical evaluation may detect adverse health effects among exposed workers 
before disease reaches advance stages[13].Medical evaluation commonly includes 
respiratory questionnaires, physical examination, chest radiography and spirometry. There 
is no universal standard as to how frequent such evaluation should be performed, because 
the decision may be influenced by past and current respirable silica concentration, dust 
particulate characteristics and economic conditions. The WHO recommends routine 
evaluation every 2–5 years, ideally ‘life-long’ for workers exposed to silica dust[19]. 
American College of Occupational and Environmental Medicine (ACOEM) recommended 
evaluation at baseline and after 1 year, then 3-yearly for the first 10 years and 2-yearly 
thereafter when silicosis is the major concern and respirable silica levels are below 0.05 
mg/m3[20]. Biomarkers of early disease could potentially benefit prevention efforts and 
clinical diagnosis. While a number of biomarkers have shown some promising results, none 
of them have been validated fully for clinical use so far[21]. The occurrence of a new case of 
silicosis is a sentinel health event to prompt a thorough evaluation of silica exposure levels 
and control measures in workplace[22]. In addition to reporting new cases, occupational 
health doctors or hygienists should periodically analyze health records from all workers in 
an industry or plant and assess the effects of prevention activities.  
3.3 Chronic obstructive pulmonary diseases 
In the past few years a new definition has been presented by Global Initiative on 
Obstructive Lung Disease (GOLD) and by a Task Force of the American Thoracic Society 
(ATS) and the European Respiratory Society (ERS). Both GOLD and ATS/ERS state that 
“COPD is a disease state characterized by airflow limitation that is not fully reversible. The 
airflow obstruction is usually both progressive and associated with an abnormal 
inflammatory response of the lungs to noxious particles and gas.”  The ATS/ERS definition 
also state that COPD is both preventable and treatable and that COPD is systemic 
disease[23]. 
Epidemiology  
According to WHO estimates, 80 million people have moderate to severe chronic 
obstructive pulmonary disease (COPD). More than 3 million people died of COPD in 2005, 
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which corresponds to 5% of all deaths globally. In 2002 COPD was the fifth leading cause of 
death, and expected to become the third leading cause of death globally by 2030, trailing 
only ischemic heart disease and cerebrovascular disease[24]. 
During 2000--2005, COPD was the underlying cause of death for 718,077 persons overall 
aged >25 years in the United States. In 2005, approximately one in 20 deaths in the United 
States had COPD as the underlying cause[25]. COPD has a prevalence of 4 to 10 percent in 
adults in populations in whom lung function has been measured. The National Health 
Interview Survey, an annual survey of approximately 40,000 United States households, has 
yielded an estimate of 10 million adults in the United States with a physician-based 
diagnosis of COPD. Other estimates, such as that from the Third National Health and 
Nutrition Examination Survey (NHANES III), that included spirometry along with 
questionnaires and a physical examination, done between 1988 and 1994, have yielded even 
more impressive prevalence figures. According to NHANES III, COPD affects 23.6 million 
adults in the United States, of whom 2.4 million have severe disease. Thus, approximately 10 
percent of the United States adult population might be classified as having COPD, and of 
this group about 10 percent have advanced disease[23]. 
According to data published by the Chinese Ministry of Health, COPD ranks as the fourth 
leading cause of death in urban areas and third leading in rural areas [16]. The overall 
prevalence of COPD in China was 8.2% (95% CI, 7.9–8.6) according to GOLD diagnostic 
criteria. The crude prevalence of COPD was the highest in Chongqing and lowest in 
Shanghai among urban areas and was highest in Guangdong and lowest in Liaoning and 
Shangxi among rural areas. The COPD prevalence was significantly higher in rural areas 
compared with urban areas[26]. Both crude and age-adjusted COPD mortality rates have 
fluctuated but have displayed a decreasing trend from 1990 which is probably because of 
improved management of COPD, upgraded technologies, and awareness of the 
disease[24]. 
Risk factors 
There are two types of risk factors for COPD: host factor and exposures (table 4). 
 
ENVIRONMENT EXPOSURES HOST FACTORS 
Smoking Genetic mutations 
Occupational exposures Airway hyperresponsiveness 
Air pollution Reduced lung growth 
Childhood respiratory infections 
Low socioeconomic status 
Table 4. Common risk factors for COPD 
Cigarette smoking is the major risk factor for COPD. However, relevant information from 
the literature published within the last years, either on general population samples or on 
workplaces, indicates that about 15% of all cases of COPD is work-related[27]. A 1989 study 
of black goldminers showed that the risk of chronic airflow limitation increases with 
duration of underground exposure and is an effect that is independent of the presence of 
silicosis. A study of white South African gold miners showed that the forced expiratory 
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volume in one second (FEV1), and the FEV1/FVC ratio, adjusted for age, height, and 
tobacco smoking, decreased with increasing cumulative respirable dust exposure, in both 
smokers and non-smokers. The average cumulative dust exposure attributables loss in lung 
function[28].  
Pathology 
COPD includes two main diseases: bronchitis - in which inflammation of the bronchi (tubes 
carrying air to and from the lung) both narrows them and causes chronic bronchial 
secretions. Chronic bronchitis is defined by the presence of cough and sputum production 
on most days for three or more months of the year for two or more consecutive years[29]; 
and emphysema - a permanent destructive enlargement of the airspaces within the lung 
without any accompanying fibrosis of the lung tissue. Asthma may also be included within 
the term COPD if there is some degree of chronic airway obstruction. 
In COPD, inflammation causes direct destruction of lung tissues and also impairs defense 
mechanisms used to repair damaged tissues. This results in not only destruction of the lung 
parenchyma, but also mucus hypersecretion, and airway narrowing and fibrosis. 
A wide range of inflammatory cells and mediators are involved in the pathogenesis  
of COPD, namely neutrophils, macrophages, and CD8+ T cells in different areas of the 
lung.  
Overall, COPD pathogenesis can be summarized as resulting from a combination of genetic 
susceptibility combined with environmental exposures which lead to inflammatory 
processes that disrupt the balance of proteases and antiprotease. These abnormal 
inflammatory mechanisms result in tissue destruction, airway inflammation and 
remodeling, and ultimately airway limitation. These imbalances and the presence of 
inflammation may result in a “positive feedback loop,” in which inflammation induces these 
imbalances, and the imbalances promote more inflammation. Once the inflammatory 
responses are set in motion, three types of damages to the lung occur: disruption of the 
alveolar walls, mucus hypersecretion contributing to airway obstruction, and fibrosis of the 
bronchioles.To support the inflammation mechanism further, a study shows there is a 
stepwise increase in alveolar inflammation has been found in surgical specimens from 
patients without COPD versus patients with mild or severe emphysema. As part of the 
peripheral airway system, the bronchioles are the major site of airway obstruction in 
COPD[30]. 
Diagnosis 
The diagnosis of COPD, classification of its severity, and progression of the disease can be 
monitored with spirometry. A test that measures the forced expiratory volume in one 
second (FEV1), which is the greatest volume of air that can be breathed out in the first 
second of a large breath. Spirometry also measures the forced vital capacity (FVC), which 
is the greatest volume of air that can be breathed out in a whole large breath. Normally, at 
least 70% of the FVC comes out in the first second (i.e. the FEV1/FVC ratio is >70%). A 
ratio less than normal defines the patient as having COPD. More specifically, the 
diagnosis of COPD is made when the FEV1/FVC ratio is <70%. The GOLD criteria also 
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require that values are after bronchodilator medication has been given to make the 
diagnosis, and the NICE criteria also require FEV1%. According to the ERS criteria, it is 
FEV1% predicted that defines when a patient has COPD, that is, when FEV1% predicted is 
< 88% for men, or < 89% for women[31]. Once airflow obstruction is established, the 
severity of the disease is classified by the reduction of FEV 1 compared with a healthy 
reference population. Table 5 shows the widely used GOLD classification of COPD 
severity based on the FEV1. 
 
STAGE CHARACTERISTICS 
I Mild COPD FEV1 80% predicted 
II Moderate COPD FEV1 50% - 79% predicted 
III Severe COPD FEV1 30% - 49%  predicted 
IV Very Severe COPD FEV1 < 30% predicted or < 50% predicted with room air 
Pao2 < 60 mmHg (8.0KPa) 
Table 5. Classification of COPD severity 
On chest x-ray, the classic signs of COPD are overexpanded lung, a flattened diaphragm, 
increased retrosternal airspace, and bullae[32]. A high-resolution computed tomography 
scan of the chest may show the distribution of emphysema throughout the lungs and can 
also be useful to exclude other lung diseases. 
Treatment 
Directions about the management and prevention of work-related diseases [33-35], can be 
applied to COPD as well. Physicians should attempt to understand the patient's 
occupational exposure and whether he/she has been adequately trained in the dangers of 
these exposures and how to manage them. Removal of the respiratory irritants and 
substitution of non-toxic agents are the best approach because they eliminate the work-
related COPD hazard. If substitution is not possible, ongoing maintenance of engineering 
controls, such as enclosure of the industrial process and improving work area ventilation, 
are useful. Administrative controls (e.g., transfer to another job or change in  
work practices), and personal protective equipment (e.g., masks or respirators)  
should be mentioned, although less effective in decreasing exposures to respiratory tract 
irritants.   
3.4 Asthma 
Occupational asthma is a lung disorder in which substances found in the workplace cause 
the airways of the lungs to swell and narrow, leading to attacks of wheezing, shortness of 
breath, chest tightness, and coughing. 
Causes and prevalence  
Though the actual rate of occurrence of occupational asthma is unknown, it is suspected to 
cause 2 - 20% of all asthma cases in industrialized nations. In the USA, OA is considered the 
most common occupational lung disease[33]. At present, over 400 workplace substances 
have been identified as having asthmagenic or allergenic properties. Their existence and 
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magnitude vary from region to region and the type of industry and can be as varied as 
wood dust (cedar, ebony, etc.), persulfates (Hairsprays), zinc or even seafood like prawns. In 
south-eastern Nigeria, a study was done to determine the magnitude of the problem among 
woodworkers exposed to high level of wood dust. Five hundred and ninety one 
woodworkers were selected using a stratified random sampling. The prevalence of 
occupational rhinitis was 78%, while that of asthma was 6.5%. As period of woodwork 
increased the prevalence of rhinitis and asthma increased (rhinitis: chi2 trend = 53.015, df =  
1,  P  =  0.000; asthma,  chi2  trend  =  19.721,  df  =  1,  P  =  0.000). It demonstrates that the 
prevalence of rhinitis and asthma in woodworkers was high and significantly increased 
with years of working as a woodworker[34]. 
Occupations at risk 
The riskiest occupations for asthma are: adhesive handlers (e.g. acrylate), animal handlers 
and veterinarians (animal proteins), bakers and millers (cereal grains), carpet makers 
(gums), electronics workers (soldering resin), forest workers, carpenters and cabinetmakers 
(wood dust), hairdressers (e.g. persulfate), health care workers (latex and chemicals such as 
glutaraldehyde), janitors and cleaning staff (e.g. chloramine-T), pharmaceutical workers 
(drugs, enzymes), seafood processors, shellac handlers (e.g. amines), solderers and refiners 
(metals), spray painters, insulation installers, plastics and foam industry workers (e.g. 
diisocyanates), textile workers (dyes) and users of plastics and epoxy resins (e.g. 
anhydrides)[35].  
Mechanism 
Even if the precise causative mechanism of occupational asthma is unknown, several 
mechanisms have been proposed, i.e. immunological, pharmacological and genetic 
mechanisms, and airway and neurogenic inflammation. More than one mechanism may 
be operative in occupational asthma. Whether various mechanisms are involved in 
occupational asthma induced by different agents is also unknown. An agent which causes 
asthma may be considered as "inducer" (i.e. causing reversible airway bronchoconstriction 
associated with long-lasting airway hyperresponsiveness to nonspecific and/or specific 
agents) or as "inciter" (i.e. triggering asthma attacks)[36]. Among the mechanisms 
proposed in the pathogenesis of occupational asthma, the immunological one plays a key 
role[35]. 
Diagnosis 
Diagnosis of OA is a process and has to be done over a period of time. First, the patient’s 
occupational and clinical history is taken and his symptoms are charted (Charting is usually 
done at the end of a typical work week and within 24 hours of the occurrence of symptoms 
in order to get objective information). Once this has been established, the following 
diagnostic methods are used: 
1. Blood tests to look for antibodies to the substance; 
2. Bronchial provocation test (test measuring reaction to the suspected allergen); 
3. Chest x-ray; 
4. Complete blood count; 
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5. Peak expiratory flow rate; 
6. Pulmonary function tests. 
Treatment 
According to the Canadian Centre for Occupational Health and Safety (CCOHS), better 
education of workers, management, unions and medical professionals is the key to the 
prevention of OA. This will enable them to identify the risk factors and put in place 
preventive measures like masks or exposure limits, etc. 
Avoiding exposure to the substance which causes you asthma is the best treatment. The best 
option is to change your jobs, or using a respiratory device to protect yourselves is an 
alternative option. 
Anyone diagnosed with Asthma will have to undergo medical treatment. This is 
complementary to either removing or reducing the patient’s exposure to the causal 
agents. 
3.5 Pulmonary tuberculosis 
Pulmonary tuberculosis, or TB, is a communicative disease caused by the bacterium 
Mycobacterium tuberculosis and, less frequently, M.bovis. Lesions most often occur in the 
lungs.  
Species of Mycobacterium are characterized by unusual “acid fast” staining properties, 
slow growth, relative resistance to chemical disinfectants, and ability to survive for 
decades with cells in the infected animal. The few studies of TB as an occupational hazard 
suggest that physicians, nurses, medical laboratory workers, and miners are at increased 
risk of TB. 
The symptoms of active TB of the lung are coughing, sometimes with sputum or blood, 
chest pains, weakness, weight loss, fever and night sweats. Tuberculosis is treatable with a 
six-month course of antibiotics. 
Epidemiology 
Roughly a third of the world's population has been infected with M. tuberculosis, and new 
infections occur at a rate of one per second. In 2007, an estimated 13.7 million people had 
active TB disease, with 9.3 million new cases and 1.8 million deaths; the annual incidence 
rate varied from 363 per 100,000 in Africa to 32 per 100,000 in the Americas[37]. In 2007, the 
country with the highest estimated incidence rate of TB was Swaziland, with 1200 cases per 
100,000 people. India had the largest total incidence, with an estimated 2.0 million new 
cases[37]. According to the statistic data released by the Chinese Ministry of Health in July 
2011, the recorded cases of pulmonary tuberculosis is 112647 which is the second in the 
recorded cases of notifiable disease, and 170 deaths. 
However, few studies of TB incidence among various occupational have been reported. 
Therefore, only general and somewhat unsatisfactory comments can be made about TB as an 
occupational hazard. 
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Miners and others who work in poorly ventilated areas are more likely to be infected by a 
fellow worker who has TB than a person who works in a well-ventilated areas[38]. 
Silicotuberculosis 
Both silica dust exposure and silicosis are risk factors for TB. Tuberculosis in a person with 
established silicosis is termed silicotuberculosis. The risk of developing TB increases with 
duration of exposure to silica dust even in the absence of silicosis. The presence of silicosis 
increases the risk of pulmonary TB approximately four fold, with the risk rising as 
radiological become more severe. This increased risk of TB associated with silicosis is 
lifelong, continuing after silica exposure ceases. 
The presence of silicosis in the lungs can be modify the natural history of TB and may alter 
its radiological appearance. The interaction of TB and silicosis is very damaging to the lung, 
unless the TB is diagnosed and treated early. 
Pathology 
Infection with Mycobacterium tuberculosis results most commonly from infected aerosol 
exposure through the lungs or mucous membranes. In immunocompetent individuals, this 
usually produces a latent/dormant infection, only about 5% of these individuals later show 
evidence of clinical disease. 
TB infection begins when the mycobacteria reach the pulmonary alveoli, where they invade 
and replicate within the endosomes of alveolar macrophages[39]. The primary site of 
infection in the lungs is generally located in either the upper part of the lower lobe, or the 
lower part of the upper lobe[39]. Bacteria are picked up by dendritic cells, which do not 
allow replication, although these cells can transport the bacilli to local (mediastinal) lymph 
nodes. Further spread is through the bloodstream to other tissues and organs where 
secondary TB lesions can develop in other parts of the lung (particularly the apex of the 
upper lobes), peripheral lymph nodes, kidneys, brain, and bone[40]. 
Workers exposed to silica are more likely to have TB because silica interferes with the 
function of the pulmonary macrophages[38]. 
Diagnosis and Treatment 
The diagnosis of tuberculosis is confirmed by the growth of Mycobacterium tuberculosis from 
culture of sputum, CSF, urine, lymph nodes, or other infected tissue. If necessary, the 
patient should have a positive tuberculin shin test. 
The goal of treatment is to cure the infection with drugs that fight the TB bacteria. Treatment 
of active pulmonary TB will always involve a combination of many drugs (usually four 
drugs). All of the drugs are continued until lab tests show which medicines work best. The 
most commonly used drugs include: Isoniazid, Rifampin, Pyrazinamide and Ethambutol. 
Prevention  
Transmission of TB can be prevented by the rapid identification and treatment of persons 
with disease and by the identification and treatment of those persons infected but not yet 
diseased.  
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As indicated above, chronic inhalation of dust particles has been linked for decades with 
lung diseases such as silicosis and silicotuberculosis. Also studies have suggested that dust 
particles may increase risk of lung cancer as well as some other diseases. 
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